# Feasibility Study for Repurposing RET Inhibitors

> **NCT07146893** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **University of Oklahoma** · enrollment: 7 (estimated)

## Conditions studied

- Cachexia-Anorexia Syndrome

## Interventions

- **DRUG:** Selpercatinib
- **OTHER:** Strength Assessment

## Key facts

- **NCT ID:** NCT07146893
- **Lead sponsor:** University of Oklahoma
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-26
- **Primary completion:** 2027-02-23
- **Final completion:** 2028-02-23
- **Target enrollment:** 7 (ESTIMATED)
- **Last updated:** 2026-01-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07146893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07146893, "Feasibility Study for Repurposing RET Inhibitors". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07146893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*